Who owns X4 Pharmaceuticals Inc?
- Ticker: XFOR
- CUSIP Number: 98420x103
Tip: Access positions for across all investors
Analyze quarterly positions in X4 Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of X4 Pharmaceuticals stock
Who bought or sold X4 Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 15M | $13M | 0% | Dec 2023 |
|
| Vanguard Group | 8.0M | $6.7M | 2% | Dec 2023 |
|
| OrbiMed Advisors | 7.1M | $6.0M | 0% | Dec 2023 |
|
| Perceptive Advisors | 3.5M | $3.0M | 0% | Dec 2023 |
|
| Kingdon Capital Management | 3.5M | $2.9M | 76% | Dec 2023 |
|
| Citadel Advisors | 1.8M | $1.5M | -10% | Dec 2023 |
|
| Millennium Management | 1.7M | $1.4M | -54% | Dec 2023 |
|
| GSA Capital Partners | 945k | $793k | 52% | Dec 2023 |
|
| Point72 Asset Management | 650k | $545k | 0% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 549k | $461k | -6% | Dec 2023 |
|
| Propel Bio Management | 535k | $449k | 100% | Dec 2023 |
|
| Barclays | 530k | $443k | 39% | Dec 2023 |
|
| Simplify Asset Management | 400k | $335k | 0% | Dec 2023 |
|
| Royce & Associates | 388k | $326k | 226% | Dec 2023 |
|
| Bank of New York Mellon | 346k | $290k | -27% | Dec 2023 |
|
| Charles Schwab Investment Management | 324k | $272k | 0% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 284k | $238k | 508% | Dec 2023 |
|
| Bank of America Corporation | 213k | $178k | -43% | Dec 2023 |
|
| AQR Capital Management | 164k | $138k | 168% | Dec 2023 |
|
| Rhumbline Advisers | 160k | $135k | 0% | Dec 2023 |
|
| Jane Street | 129k | $108k | 867% | Dec 2023 |
|
| Virtu Financial | 128k | $107k | 100% | Dec 2023 |
|
| Stifel Financial | 91k | $76k | 13% | Dec 2023 |
|
| Amundi | 81k | $67k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 80k | $67k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 73k | $61k | 47% | Dec 2023 |
|
| Squarepoint Ops | 65k | $54k | 100% | Dec 2023 |
|
| American International | 61k | $51k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 55k | $46k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 52k | $43k | -1% | Dec 2023 |
|
| SG Americas Securities | 48k | $40k | 39% | Dec 2023 |
|
| Alliancebernstein | 46k | $38k | 0% | Dec 2023 |
|
| Vontobel Holding | 45k | $38k | 0% | Dec 2023 |
|
| Wolverine Trading | 41k | $35k | 0% | Dec 2023 |
|
| Bayesian Capital Management | 39k | $33k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 39k | $33k | 118% | Dec 2023 |
|
| Wells Fargo & Company | 35k | $29k | 27% | Dec 2023 |
|
| Florida State Board of Administration | 32k | $27k | 100% | Dec 2023 |
|
| Pnc Financial Services | 30k | $25k | -1% | Dec 2023 |
|
| Walleye Trading Advisors | 30k | $25k | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 27k | $23k | 0% | Dec 2023 |
|
| Commonwealth Equity Services | 25k | $21k | -6% | Dec 2023 |
|
| Private Advisor | 22k | $18k | 0% | Dec 2023 |
|
| Bleichroeder | 18k | $15k | 0% | Dec 2023 |
|
| Citigroup | 18k | $15k | 25826% | Dec 2023 |
|
| Hrt Financial | 17k | $14k | 100% | Dec 2023 |
|
| Victory Capital Management | 17k | $14k | 24% | Dec 2023 |
|
| Principal Financial Group | 17k | $14k | 2% | Dec 2023 |
|
| LexAurum Advisors | 16k | $13k | 0% | Dec 2023 |
|
| Grimes & Company | 15k | $21k | 0% | Mar 2024 |
|
| Total Clarity Wealth Management | 14k | $19k | 100% | Mar 2024 |
|
| Pathstone Holdings | 13k | $11k | 100% | Dec 2023 |
|
| Legal & General Group | 11k | $9.5k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 10k | $8.5k | 0% | Dec 2023 |
|
| Mission Wealth Management | 10k | $8.4k | 100% | Dec 2023 |
|
| Lazari Capital Management | 10k | $8.4k | 100% | Dec 2023 |
|
| Ronald Blue Trust | 8.5k | $9.0k | 0% | Dec 2023 |
|
| Amalgamated Bank | 4.2k | $6.0k | -71% | Mar 2024 |
|
| ICA Group Wealth Management | 2.6k | $2.2k | 100% | Dec 2023 |
|
| Hartland & Co | 2.1k | $1.8k | 0% | Dec 2023 |
|
| Cubist Systematic Strategies | 1.6k | $1.4k | -34% | Dec 2023 |
|
| UBS Group | 1.2k | $1.0k | -99% | Dec 2023 |
|
| Simplex Trading | 962.00 | $0 | -93% | Dec 2023 |
|
| CWM | 7.00 | $0 | 100% | Mar 2024 |
|
Who sold out of X4 Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tri Locum Partners | Sep 2023 | 6.2M | $6.8M |
| Monashee Investment Management | Sep 2023 | 427k | $466k |
| MetLife Investment Advisors | Sep 2023 | 65k | $71k |
| Deutsche Bank Aktiengesellschaft | Sep 2023 | 61k | $67k |
| Two Sigma Securities | Sep 2023 | 32k | $35k |
| Marshall Wace | Sep 2023 | 13k | $14k |
| 1620 Investment Advisors | Sep 2023 | 10k | $11k |
| Metropolitan Life Insurance Company | Sep 2023 | 6.8k | $7.4k |